SamirVasantParikhMDFASN
Nephrology • Columbus, OHGlomerular Disease, Hereditary Kidney Disease Genetics
Professor of Clinical Medicine, Nephrology at The Ohio State University
Dr. Parikh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
543 Taylor Ave
Columbus, OH 43203Phone+1 614-293-4837Fax+1 614-293-3125
Summary
- Dr. Samir Parikh is a nephrologist in Columbus, OH and is affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute. He received his medical degree from University of Cincinnati College of Medicine and has been in practice 11 years. He specializes in the glomerular diseases with a special focus in the management of lupus nephritis, thrombotic microangiopathy and monoclonal gammopathy. He is experienced in hypertension, general nephrology, acute renal failure, and chronic kidney disease management.
Education & Training
Ohio State University HospitalFellowship, Nephrology, 2009 - 2011- Ohio State University HospitalResidency, Internal Medicine, 2006 - 2009
University of Cincinnati College of MedicineClass of 2006
Certifications & Licensure
OH State Medical License 2006 - 2026- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- MEmbranous Nephropathy Trial Of Rituximab Start of enrollment: 2011 Nov 01
- ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis Start of enrollment: 2013 Jul 01
- Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) Start of enrollment: 2013 Nov 20
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsInhibition of complement factor C5a or C5aR for cholesterol crystal embolism-related vascular thrombosis with microvascular injury and its consequences.Danyang Zhao, Chao Han, Elmina Mammadova-Bach, Kanako Watanabe-Kusunoki, Tamisa Seeko Bandeira Honda
Kidney International. 2024-11-01 - Plasma proteomics of acute tubular injury.Insa M Schmidt, Aditya L Surapaneni, Runqi Zhao, Dhairya Upadhyay, Wan-Jin Yeo
Nature Communications. 2024-08-27 - 1 citationsGenome-Wide CRISPR Screen Identifies Phospholipid Scramblase 3 as the Biological Target of Mitoprotective Drug SS-31.Josie A Silvaroli, Bijay Bisunke, Ji Young Kim, Amanda Stayton, Laura A Jayne
Journal of the American Society of Nephrology. 2024-06-01
Lectures
- Renal Biopsy: Clinical Correlations 2019American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019
Other
- Differential diagnosis and evaluation of glomerular diseaseParikh SV, Hebert LA
http://www.uptodate.com/contents/differential-diagnosis-and-evaluation-of-glomerular-disease
UpToDate, Wolters Kluwer Health - 2012-06-13
Press Mentions
Lupus Nephritis Drug Voclosporin Shows Efficacy, Safety over 3 YearsNovember 29th, 2022- Kezar Life Sciences Announces Interim Results from the MISSION Phase 2 Trial in Patients with Lupus NephritisNovember 15th, 2021
- Kezar Reports Third Quarter Financial Results and Provides Business UpdateNovember 9th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Other Languages
- Gujarati
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
